Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study of UTAA06 Injection in Treatment of Patients With Advanced Malignant Solid Tumors

NCT06372236 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT06372236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06372236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study of UTAA06 Injection in Treatment of Patients With Advanced Malignant Solid Tumors
Lead sponsor
Peking University
Phase
Phase 1
Overall status
Completed
Start date
December 5, 2023
Completion date
May 8, 2025
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

conditions or focus of study: b7-h3 positive relapsed/advanced malignant solid tumor